Additionally, salidroside regulates K+ and Ca2+ channels and activates the PI3K/AKT signaling pathway to inhibit atrial fibrillation and atrial fibrosis, thus suppressing atrial arrhythmias in heart failure models (Liu et al., 2016). This evidence concerns the gene AKT1 and heart failure.